Project Number ADDF-22 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Quantitative Profiling of Proteopathy-associated Proteins and their Fragments in Blood to Diagnose AD and FTD and to Monitor Treatment Response Research Categorization Primary Disease / Condition Frontotemporal Dementia Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Steen, Judith Principal Investigator First Name Judith Principal Investigator Last Name Steen Awardee Organization BOSTON CHILDREN'S HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $572,678 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management